Medical device manufacturers developing digital health products face a recurring question: Will the U.S. Food and Drug Administration (FDA) regulate this product? Many digital health products can ...

CONNEQT Health has taken a major step forward in its transformation from a medical device company to a scalable cloud-based ...

Forward-thinking manufacturers build native compliance protocols as a workflow, not as an afterthought—a pitfall that many ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

The Food and Drug Administration quietly told Boston-based wearable maker Whoop last week that it would not take further ...

Researcher Devashri Datta introduces AIVEX and SRIL, new approaches designed to bring context-aware risk analysis to software ...

While public conversations may often focus on chatbots and workplace automation, To sees specialized AI systems trained on ...

As artificial intelligence (AI) tools continue to reshape healthcare delivery and operations, legal and compliance teams should proactively navigate ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

A few years back, one of my surgical partners, Michael Greenwood, MD, and I had an idea for a product that would make things easier for our patients and us. That idea was to show patients what we mean ...

Publication Highlights Novel Intravenous Everolimus Formulation and Demonstrates Broad Potential of Deciparticle™ Technology for Hydrophobic ...

Insilico Medicine will partner with SK Biopharmaceuticals to discover new artificial intelligence (AI)-based drug candidates for disorders affecting the neuroimmune area of the central nervous system ...